Prestige News

Total 64
Number Thumbnail Title Author Date Votes Views
14 Prestige Biopharma Submits EMA Marketing Authorization Application for Herceptin Biosimilar HD201
김** | 2023.07.31 | Votes 0 | Views 154
김** 2023.07.31 0 154
13 Prestige Biopharma Receives FDA Fast Track Designation for PBP1510 in the Treatment of Pancreatic Cancer
김** | 2023.03.16 | Votes 0 | Views 200
김** 2023.03.16 0 200
12 Prestige Biopharma Initiates Development of PAUF-Based Diagnostic Kit for Pancreatic Cancer
김** | 2023.03.09 | Votes 0 | Views 166
김** 2023.03.09 0 166
11 Prestige Biopharma Receives Approval for Phase 1 Trial of Humira Biosimilar in Hungary
김** | 2023.02.15 | Votes 0 | Views 134
김** 2023.02.15 0 134
10 Prestige Biopharma Secures Korean Patent for PBP1710, an Antibody Therapeutic for Solid Tumors
김** | 2023.01.10 | Votes 0 | Views 105
김** 2023.01.10 0 105
9 Prestige Biopharma Attracts Over 300 Companies to Its Booth at CPHI
we******** | 2022.11.07 | Votes 0 | Views 189
we******** 2022.11.07 0 189
8 Prestige Biopharma Identifies New Biomarker for Pancreatic Cancer Treatment
we******** | 2022.10.05 | Votes 0 | Views 176
we******** 2022.10.05 0 176
7 Prestige Biopharma Receives FDA Approval for Phase 1/2a Trial of Pancreatic Cancer Drug PBP1510
김** | 2022.06.27 | Votes 0 | Views 261
김** 2022.06.27 0 261
6 Prestige Biopharma announces International Non-proprietary Name for PBP1510
김** | 2022.05.31 | Votes 0 | Views 307
김** 2022.05.31 0 307
5 Prestige Biopharma Wins “Bioprocessing Excellence in SEA” at Asia-Pacific Bioprocessing Awards 2022
김** | 2022.04.01 | Votes 0 | Views 128
김** 2022.04.01 0 128